Lu Guanming, Li Jie, Wang Shuncong, Pu Jian, Sun Huanhuan, Wei Zhongheng, Ma Yanfei, Wang Jun, Ma Haiqing
Department of Breast and Thyroid Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, China.
Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
Cancer Manag Res. 2018 Oct 30;10:4899-4914. doi: 10.2147/CMAR.S173099. eCollection 2018.
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer-related deaths among women worldwide. However, the data on breast cancer incidence and survival over a long period, especially the dynamic changes in the role of race and socioeconomic status (SES), are scant.
To evaluate treatment outcomes of patients with breast cancer over the past 3 decades, the data from the Surveillance, Epidemiology, and End Results (SEER) registries were used to assess the survival of patients with breast cancer. Period analysis was used to analyze the incidence and survival trend; survival was evaluated by the relative survival rates (RSRs) and Kaplan-Meier analyses. The HRs for age, race, stage, and SES were assessed by Cox regression.
A total of 433,366 patients diagnosed with breast cancer between 1981 and 2010 were identified from the original nine SEER registries. The incidences of breast cancer in each decade were 107.1 per 100,000, 117.5 per 100,000, and 109.8 per 100,000. The 10-year RSRs improved each decade, from 70.8% to 81.5% to 85.6% (<0.0001). The lower survival in black race and high-poverty group is confirmed by Kaplan-Meier analyses and RSRs. Furthermore, Cox regression analyses demonstrated that age, race, SES, and stage are independent risk factors for patients with breast cancer in each decade.
The current data demonstrated a fluctuating incidence trend with improving survival rates of patients with breast cancer over the past 3 decades. In addition, the survival disparity exists among different races, ages, SESs, and stages.
乳腺癌是全球女性中最常被诊断出的癌症,也是癌症相关死亡的主要原因。然而,关于乳腺癌发病率和长期生存率的数据,尤其是种族和社会经济地位(SES)作用的动态变化,却很匮乏。
为评估过去30年乳腺癌患者的治疗结果,利用监测、流行病学和最终结果(SEER)登记处的数据来评估乳腺癌患者的生存率。采用期间分析来分析发病率和生存趋势;通过相对生存率(RSR)和Kaplan-Meier分析来评估生存情况。通过Cox回归评估年龄、种族、分期和SES的风险比(HR)。
从最初的9个SEER登记处中识别出1981年至2010年间共433,366例被诊断为乳腺癌的患者。每十年的乳腺癌发病率分别为每10万人107.1例、每10万人117.5例和每10万人109.8例。每十年的10年RSR均有所提高,从70.8%提高到81.5%,再到85.6%(<0.0001)。Kaplan-Meier分析和RSR证实了黑人种族和高贫困群体的生存率较低。此外,Cox回归分析表明,年龄、种族、SES和分期是每十年乳腺癌患者的独立危险因素。
目前的数据显示,在过去30年中,乳腺癌发病率呈波动趋势,而患者的生存率有所提高。此外,不同种族、年龄、SES和分期之间存在生存差异。